α1肾上腺素能受体激动剂去氧肾上腺素通过激活ERK1/2信号通路抑制脓毒症诱导的心肌细胞凋亡和心功能障碍
该研究在脂多糖处理的成年大鼠心室肌细胞和盲肠结扎穿孔诱导的脓毒症大鼠中,探讨去氧肾上腺素对脓毒症心肌细胞凋亡的影响。去氧肾上腺素抑制脂多糖诱导的caspase-3活化,该效应被哌唑嗪逆转而不被CGP12177A逆转。去氧肾上腺素上调磷酸化ERK1/2和Bcl-2,降低TNF-α、Bax、细胞色素c释放、caspase-8/-9活性及IκBα、p38MAPK、JNK磷酸化,U0126可逆转上述效应。在脓毒症大鼠中,去氧肾上腺素抑制心肌凋亡、上调磷酸化ERK1/2、抑制心肌cTnI磷酸化并改善心功能。作者认为去氧肾上腺素通过激活ERK1/2信号通路抑制脓毒症诱导的心肌细胞凋亡和心功能障碍。
要点
- 在脂多糖处理的成年大鼠心室肌细胞中,去氧肾上腺素抑制caspase-3活化,该效应被α1肾上腺素能受体拮抗剂哌唑嗪逆转,而不被CGP12177A逆转。
- 去氧肾上腺素在脂多糖处理的成年大鼠心室肌细胞中上调磷酸化ERK1/2和Bcl-2,降低TNF-α、Bax、细胞色素c释放、caspase-8/-9活性及IκBα、p38MAPK、JNK磷酸化,上述效应均被哌唑嗪消除。
- ERK1/2特异性抑制剂U0126可逆转去氧肾上腺素对脂多糖处理成年大鼠心室肌细胞中IκBα、p38MAPK、JNK磷酸化及caspase-3/-8/-9活化的影响。
- 在盲肠结扎穿孔诱导的脓毒症大鼠中,去氧肾上腺素抑制心肌凋亡及IκBα、p38MAPK、JNK磷酸化,上调心肌磷酸化ERK1/2,抑制心肌cTnI磷酸化并改善心功能。
适用人群与场景
- 脂多糖处理的成年大鼠心室肌细胞(ARVMs)
- 盲肠结扎穿孔诱导的脓毒症大鼠
研究设计与关键结果
- 研究类型为基础实验,对象为脂多糖处理的成年大鼠心室肌细胞和盲肠结扎穿孔诱导的脓毒症大鼠。
- 在脂多糖处理的成年大鼠心室肌细胞中,去氧肾上腺素抑制caspase-3活化,哌唑嗪可逆转该效应,CGP12177A不能逆转。
- 在脂多糖处理的成年大鼠心室肌细胞中,去氧肾上腺素上调磷酸化ERK1/2和Bcl-2,降低TNF-α、Bax、细胞色素c释放、caspase-8/-9活性及IκBα、p38MAPK、JNK磷酸化,哌唑嗪可消除上述所有效应。
- 在脂多糖处理的成年大鼠心室肌细胞中,U0126逆转去氧肾上腺素对IκBα、p38MAPK、JNK磷酸化及caspase-3/-8/-9活化的影响。
- 在脓毒症大鼠中,去氧肾上腺素抑制心肌凋亡及IκBα、p38MAPK、JNK磷酸化,上调心肌磷酸化ERK1/2,抑制心肌cTnI磷酸化并改善心功能。
证据类型、等级与局限
- 证据类型:基础实验研究(细胞实验与动物实验)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究为细胞与动物实验,作者认为去氧肾上腺素通过激活ERK1/2信号通路抑制脓毒症诱导的心肌细胞凋亡和心功能障碍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
It was demonstrated that α1 adrenergic receptor (α1-AR) activation by phenylephrine (PE) attenuated cardiac dysfunction in lipopolysaccharide (LPS)-challenged mice. However, it is unclear whether PE suppresses sepsis-induced cardiomyocyte apoptosis. Here, we investigated the effects of PE on cardiomyocyte apoptosis in LPS-treated adult rat ventricular myocytes (ARVMs) and septic rats induced by cecal ligation and puncture. Cardiomyocyte apoptosis and caspase activity were detected by TUNEL and spectrophotometrical assay, respectively. Bax, Bcl-2 and cytochrome c (Cyt c) levels as well as IκBα, ERK1/2, p38 MAPK, JNK and cardiac troponin I (cTnI) phosphorylation were analyzed by Western blotting, and TNF-α concentration was analyzed by ELISA. PE inhibited LPS-induced caspase-3 activation in ARVMs, which was reversed by prazosin (a membrane permeable α1-AR antagonist), but not by CGP12177A (a membrane impermeable α1-AR antagonist). PE upregulated phosphorylated ERK1/2 and Bcl-2 contents, decreased TNF-α and Bax levels, Cyt c release, caspase-8/-9 activities as well as IκBα, p38MAPK and JNK phosphorylation in LPS-treated ARVMs, all of which were abolished by prazosin. Treatment with U0126 (a specific ERK1/2 inhibitor) reversed the effects of PE on IκBα, p38MAPK and JNK phosphorylation as well as caspase-3/-8/-9 activation in LPS-treated ARVMs. In septic rats, PE not only inhibited myocardial apoptosis as well as IκBα, p38MAPK, and JNK phosphorylation, but also upregulated myocardial phosphorylated ERK1/2. Furthermore, PE inhibited myocardial cTnI phosphorylation and improved cardiac function in septic rats. Taken together, our data suggest that α1-AR activation by PE inhibits sepsis-induced cardiomyocyte apoptosis and cardiac dysfunction via activating ERK1/2 signal pathway.
参考来源
- Li H, Xing Y, Yang D, et al. Alpha-1 Adrenergic Receptor Agonist Phenylephrine Inhibits Sepsis-Induced Cardiomyocyte Apoptosis and Cardiac Dysfunction via Activating ERK1/2 Signal Pathway. Shock. 2019. PMID: 29889817. doi:10.1097/SHK.0000000000001205
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。